Andrew Cittadine, Chief Operating Officer at Monopar Therapeutics (MNPR), bought 32,508 shares at $0.86 ($25K) on 2024-06-18, disclosed to the SEC on 2024-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.86 | 12,000 | $10K | 40.5% |
| 2 | $0.74 | 20,508 | $15K | 59.5% |
| Total | $0.78 avg | 32,508 | $25K | 100% |
| Filing → |
| MNPR | BUY | 2024-05-31 | $23K | — | Filing → |
| MNPR | BUY | 2022-11-16 | $50K | — | Filing → |